These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 12706959)

  • 1. Assessing and interpreting treatment effects in longitudinal clinical trials with missing data.
    Mallinckrodt CH; Sanger TM; Dubé S; DeBrota DJ; Molenberghs G; Carroll RJ; Potter WZ; Tollefson GD
    Biol Psychiatry; 2003 Apr; 53(8):754-60. PubMed ID: 12706959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing response profiles from incomplete longitudinal clinical trial data under regulatory considerations.
    Mallinckrodt CH; Clark SW; Carroll RJ; Molenbergh G
    J Biopharm Stat; 2003 May; 13(2):179-90. PubMed ID: 12729388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of correlation structure on treatment contrasts estimated from incomplete clinical trial data with likelihood-based repeated measures compared with last observation carried forward ANOVA.
    Mallinckrodt CH; Kaiser CJ; Watkin JG; Molenberghs G; Carroll RJ
    Clin Trials; 2004; 1(6):477-89. PubMed ID: 16279288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of duloxetine: a comprehensive summary of results from MMRM and LOCF_ANCOVA in eight clinical trials.
    Mallinckrodt CH; Raskin J; Wohlreich MM; Watkin JG; Detke MJ
    BMC Psychiatry; 2004 Sep; 4():26. PubMed ID: 15355546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MMRM vs. LOCF: a comprehensive comparison based on simulation study and 25 NDA datasets.
    Siddiqui O; Hung HM; O'Neill R
    J Biopharm Stat; 2009; 19(2):227-46. PubMed ID: 19212876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modern statistical methods for handling missing repeated measurements in obesity trial data: beyond LOCF.
    Gadbury GL; Coffey CS; Allison DB
    Obes Rev; 2003 Aug; 4(3):175-84. PubMed ID: 12916818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How should we deal with missing data in clinical trials involving Alzheimer's disease patients?
    Coley N; Gardette V; Cantet C; Gillette-Guyonnet S; Nourhashemi F; Vellas B; Andrieu S
    Curr Alzheimer Res; 2011 Jun; 8(4):421-33. PubMed ID: 21244348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention and handling of missing data in clinical trials].
    Jiang ZW; Li CJ; Wang L; Xia JL
    Yao Xue Xue Bao; 2015 Nov; 50(11):1402-7. PubMed ID: 26911032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fallacies of last observation carried forward analyses.
    Lachin JM
    Clin Trials; 2016 Apr; 13(2):161-8. PubMed ID: 26400875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accounting for dropout bias using mixed-effects models.
    Mallinckrodt CH; Clark WS; David SR
    J Biopharm Stat; 2001; 11(1-2):9-21. PubMed ID: 11459446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Move over LOCF: principled methods for handling missing data in sleep disorder trials.
    Olsen MK; Stechuchak KM; Edinger JD; Ulmer CS; Woolson RF
    Sleep Med; 2012 Feb; 13(2):123-32. PubMed ID: 22172964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marginal analysis of incomplete longitudinal binary data: a cautionary note on LOCF imputation.
    Cook RJ; Zeng L; Yi GY
    Biometrics; 2004 Sep; 60(3):820-8. PubMed ID: 15339307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparisons of methods for analysis of repeated binary responses with missing data.
    Frank Liu G; Zhan X
    J Biopharm Stat; 2011 May; 21(3):371-92. PubMed ID: 21442514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consequences of handling missing data for treatment response in osteoarthritis: a simulation study.
    Olsen IC; Kvien TK; Uhlig T
    Osteoarthritis Cartilage; 2012 Aug; 20(8):822-8. PubMed ID: 22441031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imputation of missing variance data using non-linear mixed effects modelling to enable an inverse variance weighted meta-analysis of summary-level longitudinal data: a case study.
    Boucher M
    Pharm Stat; 2012; 11(4):318-24. PubMed ID: 22566382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of alternative strategies for analysis of longitudinal trials with dropouts.
    Liu G; Gould AL
    J Biopharm Stat; 2002 May; 12(2):207-26. PubMed ID: 12413241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Handling drop-out in longitudinal clinical trials: a comparison of the LOCF and MMRM approaches.
    Lane P
    Pharm Stat; 2008; 7(2):93-106. PubMed ID: 17351897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation in analytic transparency in recent efficacy studies of antidepressant medication.
    Vannoy S; Brodt M; Cosgrove L; Shaughnessy AF
    BMJ Evid Based Med; 2018 Oct; 23(5):177-182. PubMed ID: 29950314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overview of practical approaches for handling missing data in clinical trials.
    DeSouza CM; Legedza AT; Sankoh AJ
    J Biopharm Stat; 2009 Nov; 19(6):1055-73. PubMed ID: 20183464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Missing radiographic data handling in randomized clinical trials in rheumatoid arthritis.
    Huang X; Jiao L; Wei L; Quan H; Teoh L; Koch GG
    J Biopharm Stat; 2013; 23(6):1435-52. PubMed ID: 24138441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.